Ship Healthcare Holdings (3360) AI Stock Analysis

• Market Cap: ¥183.04B
• Dividend Yield: 2.99%
• Average Volume (3M): 354.29K
• Price to Earnings (P/E): 12.1
• Beta (1Y): 0.46
• Revenue Growth: 7.49%
• EPS Growth: 9.71%
• Country: JP
• Employees: 7,793
• Sector: Healthcare
• Sector Strength: 55
• Industry: Medical - Instruments & Supplies
• EPS (TTM): 48.86
• Shares Outstanding: 101,669,400
• 10 Day Avg. Volume: 341,040
• 30 Day Avg. Volume: 354,286
• PEG Ratio: -21.20
• Price to Book (P/B): 1.80
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 22.55
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: ¥3,061.84
• Price Target Upside: 57.83% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 1

• Rating: 68 Neutral
• Price Target: ¥1,966.00 ▲(1.34%Upside)

Ship Healthcare Holdings demonstrates strong financial health, with consistent revenue growth and improved leverage, providing a solid foundation for future growth. However, technical indicators show bearish trends and weak momentum, which could pose short-term challenges. The attractive valuation offers potential upside, making it a mixed but promising opportunity in the medical instruments and supplies sector.

Ship Healthcare Holdings Business Overview & Revenue Model

Company Description

Ship Healthcare Holdings Inc. (3360) is a Japan-based company primarily engaged in the provision of comprehensive healthcare services and products. The company operates through several segments, including Medical Supply, Lifecare, Dispensing Pharmacy, and Others. Ship Healthcare Holdings offers medical equipment and supplies, constructs and manages healthcare facilities, operates nursing homes and elderly care facilities, and provides dispensing pharmacy services. Additionally, the company is involved in various healthcare-related businesses, aiming to enhance the quality of life and healthcare standards.

How the Company Makes Money

Ship Healthcare Holdings generates revenue through a diversified business model that encompasses multiple segments within the healthcare industry. The Medical Supply segment is a key revenue stream, involving the sale and distribution of medical equipment and supplies to hospitals and healthcare institutions. The Lifecare segment contributes by operating nursing homes and elderly care facilities, providing residential and day-care services for seniors. The Dispensing Pharmacy segment adds to revenue by operating pharmacies that offer prescription medications and healthcare products. Furthermore, the company engages in the construction and management of healthcare facilities, which includes partnerships with medical institutions for facility development and operation. These activities, combined with various healthcare-related services, form the core revenue streams for Ship Healthcare Holdings.

Ship Healthcare Holdings Financial Statement Overview

Summary

Ship Healthcare Holdings displays a robust financial performance with consistent revenue growth, strong profit margins, and effective cash flow management. The reduced leverage and improved return on equity enhance its financial stability, positioning the company well for future growth.

Income Statement

Ship Healthcare Holdings has demonstrated robust revenue growth over the years, with a notable increase from 514.35 billion yen in 2022 to 678.23 billion yen in 2025. The gross profit margin remains stable at around 10%, and the net profit margin improved to approximately 2.23% in 2025. EBIT and EBITDA margins have been consistent, contributing to overall profitability. The company's ability to grow revenue consistently highlights its strong market position and effective business strategy.

Balance Sheet

The balance sheet of Ship Healthcare Holdings shows a healthy equity position, with a debt-to-equity ratio improving from 0.61 in 2020 to 0.25 in 2025, indicating reduced leverage and risk. The equity ratio remains strong, reflecting financial stability. Return on equity has improved, suggesting efficient use of shareholder funds. However, the reduction in cash reserves over time and the presence of debt warrants ongoing monitoring.

Cash Flow

Operating cash flow remains strong, supporting the company's operational needs. Despite fluctuations, free cash flow has shown positive growth, with a notable increase from 8.96 billion yen in 2022 to 16.56 billion yen in 2025. The operating cash flow to net income ratio is favorable, indicating effective cash management. While capital expenditures are well-managed, continuous monitoring of financing activities is recommended.

Breakdown
TTM	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Income Statement		Total Revenue
670.20B	678.23B	630.99B	572.28B	514.35B	497.16B
	Gross Profit
66.22B	66.74B	65.61B	60.62B	53.64B	54.49B
	EBIT
24.53B	24.79B	24.54B	21.14B	20.50B	21.80B
	EBITDA
33.16B	32.19B	29.75B	28.61B	26.23B	26.30B
	Net Income Common Stockholders
17.08B	15.13B	13.79B	12.06B	12.17B	12.28B
Balance Sheet		Cash, Cash Equivalents and Short-Term Investments
72.96B	77.50B	85.07B	83.94B	77.44B	77.26B
	Total Assets
378.43B	381.70B	386.82B	381.98B	335.07B	334.50B
	Total Debt
33.83B	37.34B	57.93B	73.94B	61.22B	64.96B
	Net Debt
-39.13B	-40.16B	-27.14B	-6.90B	-12.59B	-8.95B
	Total Liabilities
230.68B	231.42B	244.60B	250.86B	212.76B	219.40B
	Stockholders Equity
145.49B	149.08B	139.52B	128.04B	118.29B	111.44B
Cash Flow		Free Cash Flow
0.00	16.56B	28.09B	10.20B	8.96B	14.76B
	Operating Cash Flow
0.00	20.38B	31.61B	14.11B	12.43B	19.77B
	Investing Cash Flow
0.00	-4.03B	-7.20B	-6.77B	-3.87B	-19.29B
	Financing Cash Flow
0.00	-24.62B	-20.48B	-1.02B	-8.84B	-10.46B

Ship Healthcare Holdings Technical Analysis

• Technical Analysis Sentiment: Neutral
• Last Price: 1940.00
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:3360, the sentiment is Neutral. The current price of 1940 is above the 20-day moving average (MA) of 1851.03, below the 50-day MA of 1953.59, and below the 200-day MA of 2064.76, indicating a neutral trend. The MACD of -11.83 indicates Negative momentum. The RSI at 54.67 is Neutral, neither overbought nor oversold. The STOCH value of 81.65 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for JP:3360.

Ship Healthcare Holdings Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
7817	80 Outperform	$140.81B	16.38	6.55%	3.76%	2.42%	-13.12%
7730	76 Outperform	¥119.65B	19.82		2.63%	11.54%	-8.30%
7716	73 Outperform	¥163.61B	28.60	4.78%	2.74%	20.53%	-75.16%
3360	68 Neutral	¥183.04B	12.10	10.34%	2.99%	7.49%	9.71%
8086	64 Neutral	€210.72B	41.21	2.07%	2.03%	9.85%	-53.97%
3593	63 Neutral	$55.24B	57.62	1.87%	2.04%	0.10%	-41.21%
Sector *	54 Neutral	$5.38B	3.31	-45.11%	3.29%	16.82%	0.04%

Ship Healthcare Holdings Corporate Events

Ship Healthcare Holdings Announces Treasury Shares Cancellation

Ship Healthcare Holdings, Inc. has announced the cancellation of 7,319,266 treasury shares, representing 7.20% of its total shares, as part of a strategic move to optimize its capital structure. This cancellation, scheduled for June 30, 2025, will result in the company having no treasury shares, potentially enhancing shareholder value and improving financial metrics.

The most recent analyst rating on (JP:3360) stock is a Buy with a Yen3080.00 price target. To see the full list of analyst forecasts on Ship Healthcare Holdings stock, see the JP:3360 Stock Forecast page.

Ship Healthcare Holdings Announces Share Buyback Plan

Ship Healthcare Holdings has announced a plan to acquire up to 3,300,000 of its own shares, valued at up to 5 billion yen, as part of its medium-term management plan. This move aims to enhance shareholder returns, improve earnings per share, and achieve a targeted return on equity of 12%, reflecting the company’s strategic focus on balancing growth investments with shareholder returns.

The most recent analyst rating on (JP:3360) stock is a Buy with a Yen3080.00 price target. To see the full list of analyst forecasts on Ship Healthcare Holdings stock, see the JP:3360 Stock Forecast page.

Ship Healthcare Introduces Restricted Stock Compensation Plan

Ship Healthcare Holdings, Inc. has announced the adoption of a restricted stock compensation plan aimed at incentivizing its directors to enhance corporate value sustainably and align their interests with shareholders. This plan, which will be proposed at the upcoming General Meeting of Shareholders, involves granting restricted stocks to eligible directors, with a total annual limit of 35,000 shares or ¥60 million in compensation, separate from existing monetary compensation.

The most recent analyst rating on (JP:3360) stock is a Buy with a Yen3220.00 price target. To see the full list of analyst forecasts on Ship Healthcare Holdings stock, see the JP:3360 Stock Forecast page.

Ship Healthcare Announces Executive Personnel Changes

Ship Healthcare Holdings, Inc. announced changes in its executive personnel following a Board of Directors meeting. Hiroshi Yokoyama will be promoted to Executive Vice President, while Hisanori Fujioka will be appointed as a new Executive Officer. These changes are set to take effect on June 27, 2025, pending approval at the Ordinary General Meeting of Shareholders. The restructuring aims to strengthen the company’s leadership and enhance its strategic direction.

The most recent analyst rating on (JP:3360) stock is a Buy with a Yen3220.00 price target. To see the full list of analyst forecasts on Ship Healthcare Holdings stock, see the JP:3360 Stock Forecast page.

Ship Healthcare Announces Dividend Distribution Plan

Ship Healthcare Holdings, Inc. announced a resolution to distribute surplus dividends, with a basis date of March 31, 2025, which will be presented to shareholders in June. The company aims to maintain a dividend payout ratio of 30% or more, reflecting its commitment to returning profits while supporting business growth and strengthening management foundations.

The most recent analyst rating on (JP:3360) stock is a Buy with a Yen3220.00 price target. To see the full list of analyst forecasts on Ship Healthcare Holdings stock, see the JP:3360 Stock Forecast page.

SHIP Healthcare Unveils ‘SHIP VISION 2030’ for Sustainable Growth

SHIP Healthcare Holdings has announced its new medium-term management plan, ‘SHIP VISION 2030’, which aims to enhance sustainable growth over the next five years. The plan focuses on optimizing group management resources and includes targets for sales growth, operating profit margin, and return on equity. The company plans to allocate significant funds for strategic investments and maintain a progressive dividend payout. Additionally, the plan emphasizes sustainability efforts, aiming to create value by addressing social issues and contributing to a well-being society.

The most recent analyst rating on (JP:3360) stock is a Buy with a Yen3220.00 price target. To see the full list of analyst forecasts on Ship Healthcare Holdings stock, see the JP:3360 Stock Forecast page.

Ship Healthcare Holdings Reports Stable Financial Growth for FY 2025

Ship Healthcare Holdings reported its consolidated financial results for the fiscal year ending March 31, 2025, showing a 7.5% increase in net sales to ¥678,229 million and a 9.6% rise in profit attributable to owners of the parent. Despite a decrease in comprehensive income, the company improved its equity capital ratio to 39.1% and increased its annual dividend to ¥58.00 per share. These results indicate a stable financial performance and a commitment to shareholder returns, positioning the company favorably in the healthcare market.

The most recent analyst rating on (JP:3360) stock is a Buy with a Yen3220.00 price target. To see the full list of analyst forecasts on Ship Healthcare Holdings stock, see the JP:3360 Stock Forecast page.